본문으로 건너뛰기
← 뒤로

Computational Analysis of Azole Derivatives Targeting the PI3K/AKT/mTOR Pathway With In Vitro Cytotoxicity and Autophagy Evaluation.

2/5 보강
Journal of biochemical and molecular toxicology 📖 저널 OA 16.1% 2022: 0/1 OA 2024: 0/2 OA 2025: 4/44 OA 2026: 14/65 OA 2022~2026 2026 Vol.40(5) p. e70859 PI3K/AKT/mTOR signaling in cancer
Retraction 확인
출처
PubMed DOI OpenAlex 마지막 보강 2026-04-29
OpenAlex 토픽 · PI3K/AKT/mTOR signaling in cancer Autophagy in Disease and Therapy Synthesis and biological activity

Regurajan R, Poomani MS, Mariappan I, Subramanian V, Sankar M, Pandi B

📝 환자 설명용 한 줄

This study aims to identify potential azole-derived inhibitors targeting the PI3K/AKT/mTOR signaling pathway involved in autophagy regulation and cancer progression.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Rathika Regurajan, Merlin Sobia Poomani, et al. (2026). Computational Analysis of Azole Derivatives Targeting the PI3K/AKT/mTOR Pathway With In Vitro Cytotoxicity and Autophagy Evaluation.. Journal of biochemical and molecular toxicology, 40(5), e70859. https://doi.org/10.1002/jbt.70859
MLA Rathika Regurajan, et al.. "Computational Analysis of Azole Derivatives Targeting the PI3K/AKT/mTOR Pathway With In Vitro Cytotoxicity and Autophagy Evaluation.." Journal of biochemical and molecular toxicology, vol. 40, no. 5, 2026, pp. e70859.
PMID 42021531 ↗
DOI 10.1002/jbt.70859

Abstract

This study aims to identify potential azole-derived inhibitors targeting the PI3K/AKT/mTOR signaling pathway involved in autophagy regulation and cancer progression. A structure-based virtual screening approach was employed using molecular docking, molecular dynamics (MD) simulations, and free energy calculations (MMGBSA and MMPBSA). The pharmacokinetic profiles and toxicity of lead compounds were assessed using ADMET analysis. In vitro validation was performed using MTT and MDC staining assays on MDA-MB-231 breast cancer cells.Among the screened compounds, KR4 demonstrated strong binding affinity towards all three kinases (-8.289, -5.222, and -6.331 kcal/mol) respectively with favorable pharmacokinetic properties. MD simulation confirmed the stability of the KR4-protein complexes, while post-MD MMPBSA analysis validated the binding energetics. In vitro studies revealed dose-dependent cytotoxicity of KR4 (IC₅₀ ≈ 39 µM) and induction of autophagy in treated cells. The integration of in silico and in vitro approaches highlights KR4 as a promising multi-target inhibitor of the PI3K/AKT/mTOR pathway with potential anti-cancer properties. These findings support further exploration of KR4 for therapeutic development.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반